IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer
J. L. Wong, P. Smith, J. Angulo-Lozano, D. Ranti, B. Bochner, J. P. Sfakianos, A. Horowitz, J. V. Ravetch, D. Knorr
This study shows that combining IL-15 with CD40 agonist antibodies improves anti-tumor immunity in bladder cancer by enhancing T cell responses and memory.
bioRxiv · Jan 30, 2023Immunology